SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ZIM Laboratories

BSE: 541400 29 Jun 2025
Healthcare
₹ 112.78
ZIM Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

ZIM Laboratories - Share Price & Details

Market Cap
₹542.0
High /Low
129.0 / 79.5
Stock P/E
44.5
Book Value
₹51.8
Dividend Yield
0.0
ROCE
8.16
ROE
₹4.96
Face Value
10.0
PEG Ratio
1.5
EVEBITDA
₹13.3
Debt
118
CMP / FCF
-29.8
Debt to equity
₹0.47
NP Ann
12.2
High price all time
153.0
Piotroski score
₹7.0
Graham Number
53.9
No. Eq. Shares
4.87
Net CF
₹-7.65
Net profit
12.2
Price to book value
2.15
Interest Coverage
₹2.58
Low price all time
14.0
Industry PE
32.7
Reserves
₹204
Free Cash Flow
₹1.08

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
ZIM Laboratories Limited1104.4348.841087.331.01542.044.5
NECTAR LIFESCIENCES LTD.NANANANA49629.2
ALBERT DAVID LTD.697.79-103.28748.93-18.148328.1

Peer Comparison Chart


About ZIM Laboratories

ZIM Laboratories Limited, with Security Code 541400, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Zim Laboratories Experiences Increased Buying Activity Amid Mixed Market Trends

(05 Jun 2025)
Zim Laboratories Ltd is experiencing notable buying activity, with the stock gaining modestly today while outperforming the declining Sensex.
Read more →

Zim Laboratories consolidated net profit declines 39.68% in the March 2025 quarter

(22 May 2025)
Sales decline 7.75% to Rs 108.73 crore. Net profit of Zim Laboratories declined 39.68% to Rs 4.88 crore in the quarter ended March 2025 as...
Read more →

Zim Laboratories Reports Declining Profits and Sales in May 2025 Financial Results

(21 May 2025)
Zim Laboratories recently released its financial results for the quarter ending March 2025, revealing a decline in key metrics.
Read more →

Investor Optimism Abounds ZIM Laboratories Limited (NSE:ZIMLAB) But Growth Is Lacking

(16 May 2025)
There wouldn't be many who think ZIM Laboratories Limited's ( NSE:ZIMLAB ) price-to-earnings (or "P/E") ratio of 29.1x...
Read more →

Zim Laboratories Hits 52-Week Low Amid Broader Market Recovery Challenges

(11 May 2025)
Zim Laboratories has reached a new 52-week low amid a broader market recovery, despite outperforming its sector intraday. The company has experienced a...
Read more →

ZIM LABORATORIES Share Price Today Down 6%

(10 May 2025)
ZIM LABORATORIES share price has plunged 6% and is presently trading at Rs 81.0. Meanwhile, the BSE HEALTHCARE index is at 41,287.9 (down...
Read more →